Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical advances in the development of novel VEGFR2 inhibitors.
Fontanella C, Ongaro E, Bolzonello S, Guardascione M, Fasola G, Aprile G. Fontanella C, et al. Among authors: guardascione m. Ann Transl Med. 2014 Dec;2(12):123. doi: 10.3978/j.issn.2305-5839.2014.08.14. Ann Transl Med. 2014. PMID: 25568876 Free PMC article. Review.
NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome.
Michelotti A, de Scordilli M, Palmero L, Guardascione M, Masala M, Roncato R, Foltran L, Ongaro E, Puglisi F. Michelotti A, et al. Among authors: guardascione m. Cells. 2021 Aug 9;10(8):2034. doi: 10.3390/cells10082034. Cells. 2021. PMID: 34440803 Free PMC article. Review.
A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer.
Poetto AS, Posocco B, Gagno S, Orleni M, Zanchetta M, Iacuzzi V, Canil G, Buzzo M, Montico M, Guardascione M, Basile D, Pelizzari G, Alberti M, Gerratana L, Puglisi F, Toffoli G. Poetto AS, et al. Among authors: guardascione m. J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Nov 15;1185:122985. doi: 10.1016/j.jchromb.2021.122985. Epub 2021 Oct 11. J Chromatogr B Analyt Technol Biomed Life Sci. 2021. PMID: 34700133
CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients.
Dalle Fratte C, Gagno S, Roncato R, Polesel J, Zanchetta M, Buzzo M, Posocco B, De Mattia E, Borsatti R, Puglisi F, Foltran L, Guardascione M, Buonadonna A, Cecchin E, Toffoli G. Dalle Fratte C, et al. Among authors: guardascione m. Br J Clin Pharmacol. 2023 Mar;89(3):1089-1098. doi: 10.1111/bcp.15551. Epub 2022 Oct 19. Br J Clin Pharmacol. 2023. PMID: 36178950 Free article.
Preoperative treatments in borderline resectable and locally advanced pancreatic cancer: Current evidence and new perspectives.
de Scordilli M, Michelotti A, Zara D, Palmero L, Alberti M, Noto C, Totaro F, Foltran L, Guardascione M, Iacono D, Ongaro E, Fasola G, Puglisi F. de Scordilli M, et al. Among authors: guardascione m. Crit Rev Oncol Hematol. 2023 Jun;186:104013. doi: 10.1016/j.critrevonc.2023.104013. Epub 2023 Apr 26. Crit Rev Oncol Hematol. 2023. PMID: 37116817 Review.
Second-line treatment strategies for RAS wild-type colorectal cancer: A systematic review and Network Meta-analysis (NMA).
Di Nardo P, Basile D, Siciliano A, Pelizzari G, Corvaja C, Buriolla S, Ongaro E, Maria Grazia D, Garattini SK, Foltran L, Guardascione M, Casagrande M, Buonadonna A, Prantera T, Aprile G, Puglisi F. Di Nardo P, et al. Among authors: guardascione m. Dig Liver Dis. 2024 May;56(5):786-794. doi: 10.1016/j.dld.2023.07.013. Epub 2023 Aug 14. Dig Liver Dis. 2024. PMID: 37586908 Review.
91 results